Article
Two-Stage CD8 <sup>+</sup> CAR T-Cell Differentiation in Patients with Large B-Cell Lymphoma
2025-03-11
Abstract excerpt
<h4>SUMMARY</h4> Chimeric antigen receptor (CAR) T-cell therapy has expanded therapeutic options for patients with diffuse large B-cell lymphoma (DLBCL). However, progress in improving clinical outcomes has been limited by an incomplete understanding of CAR T-cell differentiation in patients. To comprehensively investigate CAR T-cell differentiation in vivo, we performed single-cell, multi-modal, and longitudinal...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- deaddf63-2d42-5ff9-8699-2725be640237
- DOI
- 10.1101/2025.03.05.641715
